These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30878825)

  • 101. Azaindole therapeutic agents.
    Motati DR; Amaradhi R; Ganesh T
    Bioorg Med Chem; 2020 Dec; 28(24):115830. PubMed ID: 33161343
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Development of Novel Small-Molecule Activators of Pyruvate Kinase Muscle Isozyme 2, PKM2, to Reduce Photoreceptor Apoptosis.
    Wubben TJ; Chaudhury S; Watch BT; Stuckey JA; Weh E; Fernando R; Goswami M; Pawar M; Rech JC; Besirli CG
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242488
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Molecular determinants of sensitivity to antitumor agents.
    Kastan MB
    Biochim Biophys Acta; 1999 Jul; 1424(1):R37-42. PubMed ID: 10456034
    [No Abstract]   [Full Text] [Related]  

  • 104. Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza.
    Bandarage UK; Clark MP; Perola E; Gao H; Jacobs MD; Tsai A; Gillespie J; Kennedy JM; Maltais F; Ledeboer MW; Davies I; Gu W; Byrn RA; Nti Addae K; Bennett H; Leeman JR; Jones SM; O'Brien C; Memmott C; Bennani Y; Charifson PS
    ACS Med Chem Lett; 2017 Feb; 8(2):261-265. PubMed ID: 28197323
    [TBL] [Abstract][Full Text] [Related]  

  • 105. A natural PKM2 targeting agent as a potential drug for breast cancer treatment.
    Shang XY; Wang YJ; Hou ZL; Wang XY; Zhang H; Yang CY; Li JC; Huang XX; Song SJ; Yao GD
    Clin Transl Med; 2023 Jan; 13(1):e1157. PubMed ID: 36579385
    [No Abstract]   [Full Text] [Related]  

  • 106. Compound nucleus in Livs.
    Avishai Y
    Phys Rev A Gen Phys; 1988 Jul; 38(2):584-590. PubMed ID: 9900416
    [No Abstract]   [Full Text] [Related]  

  • 107. The Role of PKM2 in the Regulation of Mitochondrial Function: Focus on Mitochondrial Metabolism, Oxidative Stress, Dynamic, and Apoptosis. PKM2 in Mitochondrial Function.
    Gao J; Zhao Y; Li T; Gan X; Yu H
    Oxid Med Cell Longev; 2022; 2022():7702681. PubMed ID: 35571239
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents.
    Rathod B; Chak S; Patel S; Shard A
    RSC Med Chem; 2021 Jul; 12(7):1121-1141. PubMed ID: 34355179
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Protein kinase function of pyruvate kinase M2 and cancer.
    Chen X; Chen S; Yu D
    Cancer Cell Int; 2020 Oct; 20(1):523. PubMed ID: 33292198
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The role of pyruvate kinase M2 in anticancer therapeutic treatments.
    Su Q; Luo S; Tan Q; Deng J; Zhou S; Peng M; Tao T; Yang X
    Oncol Lett; 2019 Dec; 18(6):5663-5672. PubMed ID: 31788038
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 112. New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds.
    Zhang Y; Liu B; Wu X; Li R; Ning X; Liu Y; Liu Z; Ge Z; Li R; Yin Y
    Bioorg Med Chem; 2015 Aug; 23(15):4815-4823. PubMed ID: 26081759
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pyruvate kinase activators as a therapy target: a patent review 2011-2017.
    Adem S; Comakli V; Uzun N
    Expert Opin Ther Pat; 2018 Jan; 28(1):61-68. PubMed ID: 28994333
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors.
    Liu B; Yuan X; Xu B; Zhang H; Li R; Wang X; Ge Z; Li R
    Eur J Med Chem; 2019 May; 170():1-15. PubMed ID: 30878825
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators.
    Li R; Ning X; He J; Lin Z; Su Y; Li R; Yin Y
    Bioorg Chem; 2021 Mar; 108():104653. PubMed ID: 33517002
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators.
    Li R; Ning X; Zhou S; Lin Z; Wu X; Chen H; Bai X; Wang X; Ge Z; Li R; Yin Y
    Eur J Med Chem; 2018 Jan; 143():48-65. PubMed ID: 29172082
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.